Moreover, specifically targeting the peripheral eCB system in obese Magel2-null mice was found to be as efficacious as in DIO animals, and, therefore, it may represent a novel approach to treating obesity and its complications in PWS. Here, MAGEL2 is linked to obesity due to melanocortin 4 receptor deficiency.